These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24222607)

  • 1. Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis.
    Takagi S; Oh-hara T; Sato S; Gong B; Takami M; Fujita N
    Int J Cancer; 2014 Jun; 134(11):2605-14. PubMed ID: 24222607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.
    Miyata K; Takagi S; Sato S; Morioka H; Shiba K; Minamisawa T; Takami M; Fujita N
    Cancer Med; 2014 Dec; 3(6):1595-604. PubMed ID: 25132683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.
    Kunita A; Kashima TG; Morishita Y; Fukayama M; Kato Y; Tsuruo T; Fujita N
    Am J Pathol; 2007 Apr; 170(4):1337-47. PubMed ID: 17392172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis.
    Nakazawa Y; Sato S; Naito M; Kato Y; Mishima K; Arai H; Tsuruo T; Fujita N
    Blood; 2008 Sep; 112(5):1730-9. PubMed ID: 18541721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
    Nakazawa Y; Takagi S; Sato S; Oh-hara T; Koike S; Takami M; Arai H; Fujita N
    Cancer Sci; 2011 Nov; 102(11):2051-7. PubMed ID: 21824222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.
    Takagi S; Sato S; Oh-hara T; Takami M; Koike S; Mishima Y; Hatake K; Fujita N
    PLoS One; 2013; 8(8):e73609. PubMed ID: 23991201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma.
    Kato Y; Kaneko M; Sata M; Fujita N; Tsuruo T; Osawa M
    Tumour Biol; 2005; 26(4):195-200. PubMed ID: 16006773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
    Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
    Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells.
    Kaneko M; Kato Y; Kunita A; Fujita N; Tsuruo T; Osawa M
    J Biol Chem; 2004 Sep; 279(37):38838-43. PubMed ID: 15231832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
    Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
    Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
    Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
    Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
    Fujita N; Takagi S
    J Biochem; 2012 Nov; 152(5):407-13. PubMed ID: 22992842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor.
    Kaneko MK; Kato Y; Kitano T; Osawa M
    Gene; 2006 Aug; 378():52-7. PubMed ID: 16766141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors.
    Kato Y; Fujita N; Kunita A; Sato S; Kaneko M; Osawa M; Tsuruo T
    J Biol Chem; 2003 Dec; 278(51):51599-605. PubMed ID: 14522983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.
    Toyokawa G; Cho HS; Iwai Y; Yoshimatsu M; Takawa M; Hayami S; Maejima K; Shimizu N; Tanaka H; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2051-61. PubMed ID: 21930796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors.
    Kato Y; Sasagawa I; Kaneko M; Osawa M; Fujita N; Tsuruo T
    Oncogene; 2004 Nov; 23(52):8552-6. PubMed ID: 15361850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ppGalNAc T1 as a potential novel marker for human bladder cancer.
    Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP
    Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.
    Kato Y; Kunita A; Abe S; Ogasawara S; Fujii Y; Oki H; Fukayama M; Nishioka Y; Kaneko MK
    Oncotarget; 2015 Nov; 6(34):36003-18. PubMed ID: 26416352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
    Li CF; Chan TC; Pan CT; Vejvisithsakul PP; Lai JC; Chen SY; Hsu YW; Shiao MS; Shiue YL
    Cell Oncol (Dordr); 2021 Oct; 44(5):1133-1150. PubMed ID: 34339014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.